Acute Genital Nerve Stimulation for Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
MetroHealth Medical Center
Study ID
NCT05626816
Status
Recruiting

Conditions

  • Fecal Incontinence

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Genital Nerve Stimulation — DEVICE
    Electrical stimulation applied to the genital nerve with surface electrodes using an off the shelf TENS unit (Ultima Plus). First, an amplitude threshold for the pudendo-anal reflex responses will be determined. Then, sham (1-2 Hz) and effective stimulation (20 Hz) will be briefly applied to record responses. Then, stimulation will be applied in random presentation order to record any changes in anorectal manometry outcomes due to both sham and effective stimulation.
  • Clinical exam — DIAGNOSTIC_TEST
    Examination by physician determines the presence of pelvic reflexes (pudendo-anal and bulbocavernosus) which are essential for GNS to have an effect.
  • Collection of SCI common data elements — DIAGNOSTIC_TEST
    Data regarding participant demographics, history of injury, and medical history will be collected.
  • Bowel function survey completion — DIAGNOSTIC_TEST
    Two surveys will be conducted to assess the bowel function of the participant. The International SCI Bowel Function Basic Data Set (ISCI BF BDS v2.1) and the SCI Qulaity of Life Bowel Management Difficulties (SCI-QoL BMD) survey scales collect data on overall bowel function and how any difficulties impact the participants quality of life.
  • International Standard for Neurological Classification of SCI (ISNCSCI) — DIAGNOSTIC_TEST
    The physician will conduct the ISNCSCI to determine the level and severity of injury to the spinal cord. This is done by determining the ability to detect light touch and pinprick stimulation. Outcomes will be a Spinal Injury Association Impairment Scale (AIS) grade of A-D.
  • Response to genital nerve stimulation (GNS) — DIAGNOSTIC_TEST
    GNS will be applied to determine if there is a response in the participant. If the participant has no response to the stimulation they will be excluded from the second visit as it is dependent on the ability to respond to GNS.
  • Anorectal Manometry testing (ARM) — DIAGNOSTIC_TEST
    The participant will be instrumented for ARM testing. This requires a special balloon catheter to be inserted into the anus and secured, surface electrode pads being applied to the anal sphincter, and electrode pads being applied to the genital nerve stimulation sites. Once instrumented, the participant will be tested with the London Classification procedure. This procedure asks the participant to perform several actions (squeeze to withhold a bowel movement, push to have a bowel movement, and cough) as well as inflating the balloon on the catheter to determine reflex thresholds (RAIR, retroanal inhibitory reflex which relaxes the anal sphincter in response to rectal distension) and sensory thresholds (first senstation,

Study Details

Bowel issues occur in nearly all people after spinal cord injury (SCI) and one major complication is fecal incontinence (accidents). This complication has been repeatedly highlighted by people living with SCI as particularly life-limiting and in need of more options for interventions. This study will test the effect of genital nerve stimulation (GNS), with non-invasive electrodes, on the activity of the anus and rectum of persons after SCI. Recording anorectal manometry (ARM) endpoints tells us the function of those tissues and our study design (ARM without stim, ARM with stim, ARM without stim) will allow us to conclude the GNS effect and whether it is likely to reduce fecal incontinence. The study will also collect medical, demographic, and bowel related functional information. The combination of all of these data should help predict who will respond to stimulation, what will happen when stimulation is applied, and if that stimulation is likely to provide an improvement in fecal continence for people living with SCI.

Key Dates

Start date
Mar 21, 2023
Status verified
Nov 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
52 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: All interventions, Sham applied first
    These participants will have all interventions applied, but will be randomly designated to have sham stimulation applied before effective stimulation. This will balance any issue with order of presentation of multiple stimulation sessions.
  • Experimental: All interventions, effective stim applied first
    These participants will have all interventions applied, but will be randomly designated to have effective stimulation applied before sham stimulation. This will balance any issue with order of presentation of multiple stimulation sessions.

Primary Outcome Measure

ARM outcome - Rectal wall tension [ Time Frame: Up to three weeks after enrollment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
MetroHealth Medical System Old Brooklyn CampusClevelandOhio44109
Mayson Moore
2169573558
Robert Hoey, PhD
2169573665
Kim Anderson, PhD (PRINCIPAL_INVESTIGATOR)
Rob Hoey, PhD (PRINCIPAL_INVESTIGATOR)
Dennis Bourbeau, PhD (SUB_INVESTIGATOR)
James Wilson, DO (SUB_INVESTIGATOR)
Ronnie Fass, MD (SUB_INVESTIGATOR)
Doug Gunzler, PhD (SUB_INVESTIGATOR)

Find similar trials in Cleveland, OH

Related Studies